Rebecca M. McNeill claims as a motto “translating innovation into value” and, with 20 years of experience in biotechnology patent prosecution and counseling, offers intellectual property strategy, new application preparation, patent prosecution (US and foreign), preparation and negotiation of IP transactions, USPTO contentious practice, and the full scope of counseling services to clients of various sizes. She has worked with biotech start-ups, research foundations, universities, and pharmaceutical companies, ranging from early-stage to publicly-traded companies. Rebecca has been described as protecting clients’ inventions in a “commercially viable and strategic way” and has been ranked with an AV Preeminent® Peer Review Rating from Martindale-Hubble®. Rebecca has a special interest in counseling clients on patent application filing and developing worldwide strategies in concert with clients’ business goals. Rebecca has substantial experience in many technical areas in the life sciences. Practicing in the biotech area, Rebecca frequently balances the desire to file as early as possible with the need to generate experimental data to support broad claims. Rebecca is a regular author and speaker on patent law topics, including AIA post-grant proceedings, patent prosecution and drafting techniques, and differences between US and European patent practice. Rebecca has also held prominent leadership positions in a variety of organizations including the Boston Patent Law Association, MassBio IP Committee, and the DC Bar Board of Governors, and the Women’s Bar Association of the District of Columbia and the Women’s Bar Association Foundation.